Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714505 · ClinicalTrials.gov registry record · NA
Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01714505 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 20 participants.
The verdict
NCT01714505, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
An unblinded, randomized, cross-over design with each patient participating in two 40-hour outpatient admissions: (a) Experimental involving automated Control-to-Range (CTR) and (b) Control using Continuous Glucose Monitor (CGM)- augmented insulin pump treatment outside of a hospital based clinical research center. The principal goal is to validate a smart phone-based control-to-range (CTR) system for ambulatory use and to estimate the effect of CTR vs. sensor-augmented pump therapy, thereby providing justification for further larger home-based trials of CTR.
Interventions
- DEVICE Diabetes Assistant (DiAs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01714505
The ClinicalTrials.gov registry entry for NCT01714505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diabetes Assistant (DiAs) is the first listed.
NCT01714505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01714505 about?
NCT01714505 is a clinical study titled "Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy". An unblinded, randomized, cross-over design with each patient participating in two 40-hour outpatient admissions: (a) Experimental involving automated Control-to-Range (CTR) and (b) Control using Continuous Glucose Monitor (CGM)- augmented insulin pump treatment outside of a hospital based clinical ...
What is the current status of trial NCT01714505?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-10. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01714505?
The interventions under investigation include: Diabetes Assistant (DiAs) (DEVICE).
Who is sponsoring clinical trial NCT01714505?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.